404 related articles for article (PubMed ID: 30864193)
1. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
[TBL] [Abstract][Full Text] [Related]
2. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
[TBL] [Abstract][Full Text] [Related]
3. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
4. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
[TBL] [Abstract][Full Text] [Related]
5. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
Zaiss M; Windschuh J; Goerke S; Paech D; Meissner JE; Burth S; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
Magn Reson Med; 2017 Jan; 77(1):196-208. PubMed ID: 26845067
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
7. Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.
Yuwen Zhou I; Wang E; Cheung JS; Lu D; Ji Y; Zhang X; Fulci G; Sun PZ
Magn Reson Med; 2017 Dec; 78(6):2307-2314. PubMed ID: 29030880
[TBL] [Abstract][Full Text] [Related]
8. Accuracy in the quantification of chemical exchange saturation transfer (CEST) and relayed nuclear Overhauser enhancement (rNOE) saturation transfer effects.
Zhang XY; Wang F; Li H; Xu J; Gochberg DF; Gore JC; Zu Z
NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28272761
[TBL] [Abstract][Full Text] [Related]
9. Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T.
Xu X; Yadav NN; Zeng H; Jones CK; Zhou J; van Zijl PC; Xu J
Magn Reson Med; 2016 Jan; 75(1):88-96. PubMed ID: 26445350
[TBL] [Abstract][Full Text] [Related]
10. Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T.
Goerke S; Soehngen Y; Deshmane A; Zaiss M; Breitling J; Boyd PS; Herz K; Zimmermann F; Klika KD; Schlemmer HP; Paech D; Ladd ME; Bachert P
Magn Reson Med; 2019 Aug; 82(2):622-632. PubMed ID: 30927313
[TBL] [Abstract][Full Text] [Related]
11. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
[TBL] [Abstract][Full Text] [Related]
12. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
[TBL] [Abstract][Full Text] [Related]
13. CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
von Knebel Doeberitz N; Kroh F; Breitling J; König L; Maksimovic S; Graß S; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Radiother Oncol; 2023 Jul; 184():109694. PubMed ID: 37150450
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
[TBL] [Abstract][Full Text] [Related]
16. Clinical routine acquisition protocol for 3D relaxation-compensated APT and rNOE CEST-MRI of the human brain at 3T.
Goerke S; Breitling J; Korzowski A; Paech D; Zaiss M; Schlemmer HP; Ladd ME; Bachert P
Magn Reson Med; 2021 Jul; 86(1):393-404. PubMed ID: 33586217
[TBL] [Abstract][Full Text] [Related]
17. Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
Regnery S; Adeberg S; Dreher C; Oberhollenzer J; Meissner JE; Goerke S; Windschuh J; Deike-Hofmann K; Bickelhaupt S; Zaiss M; Radbruch A; Bendszus M; Wick W; Unterberg A; Rieken S; Debus J; Bachert P; Ladd M; Schlemmer HP; Paech D
Oncotarget; 2018 Jun; 9(47):28772-28783. PubMed ID: 29983895
[TBL] [Abstract][Full Text] [Related]
18. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
20. Isolation of amide proton transfer effect and relayed nuclear Overhauser enhancement effect at -3.5ppm using CEST with double saturation powers.
Zhao Y; Sun C; Zu Z
Magn Reson Med; 2023 Sep; 90(3):1025-1040. PubMed ID: 37154382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
